93 related articles for article (PubMed ID: 2941571)
1. Comparison of estrogenic components used for hormonal contraception.
Stanczyk FZ; Winer SA; Foidart JM; Archer DF
Contraception; 2024 Feb; 130():110310. PubMed ID: 37863464
[TBL] [Abstract][Full Text] [Related]
2. Insights into the Behavior of Triple-Negative MDA-MB-231 Breast Carcinoma Cells Following the Treatment with 17β-Ethinylestradiol and Levonorgestrel.
Simu S; Marcovici I; Dobrescu A; Malita D; Dehelean CA; Coricovac D; Olaru F; Draghici GA; Navolan D
Molecules; 2021 May; 26(9):. PubMed ID: 34066763
[TBL] [Abstract][Full Text] [Related]
3. Venous Thromboembolic Risk of Estradiol Valerate-Dienogest Compared with Ethinyl Estradiol-Levonorgestrel Combined Oral Contraceptives.
Bauerfeind A; von Stockum S; Boehnke T; Heinemann K
Obstet Gynecol; 2024 Mar; 143(3):431-434. PubMed ID: 38227942
[TBL] [Abstract][Full Text] [Related]
4. Ethynilestradiol 20 mcg plus Levonorgestrel 100 mcg: Clinical Pharmacology.
Lello S; Cavani A
Int J Endocrinol; 2014; 2014():102184. PubMed ID: 25477960
[TBL] [Abstract][Full Text] [Related]
5. Coagulation effects of oral contraception.
Bonnar J
Am J Obstet Gynecol; 1987 Oct; 157(4 Pt 2):1042-8. PubMed ID: 2960241
[TBL] [Abstract][Full Text] [Related]
6. Haemostatic changes and the oral contraceptive pill.
Norris LA; Bonnar J
Baillieres Clin Obstet Gynaecol; 1997 Sep; 11(3):545-64. PubMed ID: 9488791
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of ethinylestradiol on coagulation factors in rats.
Franco-Murillo Y; Jaimez R
Exp Anim; 2017 May; 66(2):107-113. PubMed ID: 27829580
[TBL] [Abstract][Full Text] [Related]
8. Combined oral contraceptives: the risk of myocardial infarction and ischemic stroke.
Roach RE; Helmerhorst FM; Lijfering WM; Stijnen T; Algra A; Dekkers OM
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD011054. PubMed ID: 26310586
[TBL] [Abstract][Full Text] [Related]
9. Fatal pulmonary embolus in a patient treated with Marvelon.
Scolding NJ; Gibby OM
J R Coll Gen Pract; 1988 Dec; 38(317):568. PubMed ID: 2978521
[No Abstract] [Full Text] [Related]
10. Long-term profile of a new progestin.
Lippman J
Int J Fertil; 1992; 37 Suppl 4():218-22. PubMed ID: 1362189
[TBL] [Abstract][Full Text] [Related]
11. [Metabolic impact of current estrogen-progestins and cardiovascular consequences].
Gaspard U; Lambotte R
Bull Mem Acad R Med Belg; 1991; 146(8-10):334-42; discussion 342-5. PubMed ID: 1815814
[TBL] [Abstract][Full Text] [Related]
12. Oral contraceptives and blood coagulation.
Bonnar J; Sabra AM
J Reprod Med; 1986 Jun; 31(6 Suppl):551-6. PubMed ID: 2941571
[TBL] [Abstract][Full Text] [Related]
13. Hemostatic system changes induced by 50 micrograms and 30 micrograms estrogen/progestogen oral contraceptives. Modification of estrogen effects by levonorgestrel.
Sabra A; Bonnar J
J Reprod Med; 1983 Jan; 28(1 Suppl):85-91. PubMed ID: 6834350
[TBL] [Abstract][Full Text] [Related]
14. Blood coagulation with a combination pill containing gestodene and ethinyl estradiol.
Bonnar J; Daly L; Carroll E
Int J Fertil; 1987; 32 Suppl():21-8. PubMed ID: 2906344
[TBL] [Abstract][Full Text] [Related]
15. Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives.
Quehenberger P; Loner U; Kapiotis S; Handler S; Schneider B; Huber J; Speiser W
Thromb Haemost; 1996 Nov; 76(5):729-34. PubMed ID: 8950781
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
